#Sweden #New Brand #Lund #Clinical Research #TFS HealthScience

TFS HealthScience Unveils New Global Brand Identity

TFS HealthScience, a prominent global clinical research organization (CRO) headquartered in Lund, Sweden, has recently announced a significant transformation in its brand identity. Officially launched on October 5, 2026, this new branding reflects the organization’s commitment to advancing scientific collaboration with stakeholders in biotechnology, pharmaceuticals, and medical technology across more than 40 countries.

Markus Granlund, the CEO of TFS HealthScience, described this rebranding as a perfect reflection of the company’s true identity and direction. He emphasized the new slogan, "Securing the path from science to life," which serves not only as a guiding principle but also emphasizes the company’s mission to effectively bridge clinical research to real-life applications for patients in need.

Core Values of the New Brand Identity

The newly adopted brand identity is built upon four fundamental commitments that outline how TFS HealthScience will conduct its business:

1. Radical Honesty: TFS teams are dedicated to providing sponsors with clear insights into study data, helping to identify critical points early in the process. This approach is intended to ensure transparency and trust within collaborations.

2. Scientific Urgency: With empowered therapeutic leads, TFS teams can make swift decisions, allowing sponsors to receive timely responses without unnecessary bureaucratic delays.

3. Therapeutic Depth: The organization focuses on five core therapeutic areas—Dermatology, Internal Medicine, Neuroscience, Oncology, and Ophthalmology. Clinical leads are equipped with in-depth knowledge of these areas before a project begins, facilitating effective study conduct.

4. Teams That Stay: Notably, TFS boasts an impressive retention rate of 88% among its teams, which is 8 percentage points higher than the industry average. This stability ensures consistency, as the same experts who start a study will remain until its completion.

The Commitment to Clinical Research

TFS HealthScience was founded in Lund with a clear vision of how clinical research should be carried out. The organization not only aims to communicate what the data signifies to sponsors but also prioritizes rapid actions from the moment the first patient is recruited until the data lock is finalized. This methodical and human-centered approach is meant to ensure that promising scientific discoveries reach the patients who need them most.

Furthermore, the flexibility of the service model allows clients to collaborate with TFS in various ways, whether through complete project handling, integrated staffing solutions, or a combination of both, depending on internal capabilities and outsourcing needs.

Looking Ahead

As TFS HealthScience moves forward with its revamped identity, it remains committed to fostering a culture of innovation and collaboration in clinical trials. By investing in their teams and maintaining clear communication with sponsors, TFS aims to establish itself as a leader in the field while enhancing the efficiency and impact of clinical research.

For those interested in seeing the rebranding in action, TFS has released a brand film that illustrates how their teams collaborate closely with sponsors throughout the research process, from initial patient enrollment to the completion of data collection. The film can be viewed at tfscro.com/new-brand.

In conclusion, TFS HealthScience’s new brand identity and its associated commitments represent a bold step forward in not only articulating their mission but also in reinforcing their dedication to enhancing the clinical research landscape for better patient outcomes around the globe.